SeaCrest Wealth Management LLC Sells 4,171 Shares of CVS Health Co. (NYSE:CVS)

SeaCrest Wealth Management LLC decreased its holdings in CVS Health Co. (NYSE:CVS) by 24.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 12,605 shares of the pharmacy operator’s stock after selling 4,171 shares during the quarter. SeaCrest Wealth Management LLC’s holdings in CVS Health were worth $793,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Shulman DeMeo Asset Management LLC purchased a new stake in CVS Health in the 3rd quarter valued at $175,000. Swedbank AB raised its holdings in shares of CVS Health by 0.6% in the third quarter. Swedbank AB now owns 1,388,889 shares of the pharmacy operator’s stock valued at $87,333,000 after purchasing an additional 7,620 shares during the last quarter. Creative Planning lifted its position in shares of CVS Health by 23.5% during the third quarter. Creative Planning now owns 250,891 shares of the pharmacy operator’s stock valued at $15,776,000 after purchasing an additional 47,737 shares in the last quarter. CX Institutional boosted its holdings in CVS Health by 698.0% during the third quarter. CX Institutional now owns 74,609 shares of the pharmacy operator’s stock worth $4,691,000 after purchasing an additional 65,259 shares during the last quarter. Finally, Kathleen S. Wright Associates Inc. bought a new stake in CVS Health in the 3rd quarter worth about $33,000. 80.66% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

CVS has been the topic of a number of research analyst reports. Royal Bank of Canada restated an “outperform” rating and issued a $68.00 target price on shares of CVS Health in a research note on Wednesday, September 4th. Cantor Fitzgerald restated a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a research note on Tuesday, October 1st. Wells Fargo & Company boosted their price target on shares of CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a report on Monday, August 12th. Truist Financial lifted their price objective on shares of CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a research report on Friday, October 11th. Finally, Evercore ISI raised their price target on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. Nine analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $75.26.

CVS Health Trading Up 0.0 %

Shares of CVS Health stock opened at $65.01 on Thursday. The company’s 50-day moving average price is $59.62 and its 200-day moving average price is $60.73. The company has a current ratio of 0.86, a quick ratio of 0.66 and a debt-to-equity ratio of 0.83. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The company has a market cap of $81.61 billion, a price-to-earnings ratio of 11.43, a PEG ratio of 0.93 and a beta of 0.54.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. The firm had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter last year, the company posted $2.21 EPS. On average, equities analysts expect that CVS Health Co. will post 6.51 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.09%. CVS Health’s dividend payout ratio (DPR) is presently 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.